Evidence for the presence of sodium- and potassium-dependent adenosine triphosphatase alpha1 and beta1 subunit isoforms and their probable role in blastocyst expansion in the preattachment horse conceptus.
The unusual hypotonicity of equine blastocyst fluid has prompted us to investigate the role of sodium- and potassium-dependent adenosine triphosphatase (Na+,K+-ATPase) in the process of fluid accumulation in the horse conceptus. Nine mares were used for the experiments. Reverse transcriptase polymerase chain reaction was conducted on two sets of five conceptuses recovered between 12 and 28 days (+/- 1 day) after ovulation. Messenger RNAs encoding the alpha1 and beta1 subunit isoforms of Na+,K+-ATPase were detected in all embryonic tissues examined. Western blot analysis showed that alpha1 and beta1 subunits are both present in Day 15 conceptuses. Trophoblast tissues from 19 conceptuses between 8 and 31 days after ovulation were stained immunohistochemically using primary antibodies against the alpha1 and beta1 subunit isoforms of the Na+,K+-ATPase. Both isoforms were detected in all sections. Trophoblastic vesicles, prepared from 6 conceptuses between 12 and 14 days after ovulation, were used to investigate the inhibition of blastocyst expansion with ouabain after collapse induced with cytochalasin D. In normal medium there was a mean 3-fold increase, and in ouabain (10(-6) M) a mean 3-fold decrease, in the volume of vesicles that had been partially collapsed with cytochalasin D. We therefore conclude that, despite the hypotonicity of the blastocyst fluid in the early horse conceptus, the Na+,K+-ATPase plays a role in its accumulation, as in other species.
Waelchli
R O
RO
Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Canada.
MacPhee
D J
DJ
Kidder
G M
GM
Betteridge
K J
KJ
D000818:Animals; D001483:Base Sequence; D001755:Blastocyst / Q000187:drug effects / Q000201:enzymology*; D001826:Body Fluids / Q000378:metabolism; D015638:Cytochalasin D / Q000494:pharmacology; D017931:DNA Primers / Q000235:genetics; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D006736:Horses / Q000378:metabolism*; D007150:Immunohistochemistry; D007527:Isoenzymes / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D007684:Kidney Tubules / Q000201:enzymology; D008969:Molecular Sequence Data; D009994:Osmolar Concentration; D010042:Ouabain / Q000494:pharmacology; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D011487:Protein Conformation; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D014327:Trophoblasts / Q000187:drug effects / Q000201:enzymology; D015017:Yolk Sac / Q000201:enzymology
D017931:DNA Primers; D004791:Enzyme Inhibitors; D007527:Isoenzymes; D012333:RNA, Messenger; D015638:Cytochalasin D; D010042:Ouabain; D000254:Sodium-Potassium-Exchanging ATPase